Ultralife (ULBI) Receivables (2010 - 2026)

Ultralife has reported Receivables for 17 years, with the latest figure at $34.8 million in Q2 2026.

• On a quarterly basis, Receivables rose 7.57% year-over-year to $34.8 million in Q2 2026; TTM through Jun 2026 was $34.8 million, a 7.57% increase from a year earlier, with the FY2025 full-year figure at $33.9 million, up 15.59% from the prior year.
• Receivables was $34.8 million for Q2 2026 at Ultralife, up from $34.4 million in the prior quarter.
• The five-year high for Receivables was $36.1 million in Q1 2025, with the low at $22.3 million in Q2 2022.
• Average Receivables over 5 years is $30.0 million, with a median of $30.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Receivables jumped 65.54% in 2022, then slipped 7.53% in 2024.
• Over 5 years, Receivables stood at $27.8 million in 2022, then rose by 14.33% to $31.8 million in 2023, then dropped by 7.53% to $29.4 million in 2024, then climbed by 15.59% to $33.9 million in 2025, then grew by 2.42% to $34.8 million in 2026.
• The last three Receivables figures came in at $34.8 million (Q2 2026), $34.4 million (Q1 2026), and $33.9 million (Q4 2025), per Business Quant data.